Cargando…
RNA-Sequencing of Tumor-Educated Platelets, a Novel Biomarker for Blood-Based Sarcoma Diagnostics
Sarcoma is a heterogeneous group of rare malignancies arising from mesenchymal tissues. Recurrence rates are high and methods for early detection by blood-based biomarkers do not exist. Hence, development of blood-based liquid biopsies as disease recurrence monitoring biomarkers would be an importan...
Autores principales: | Heinhuis, Kimberley M., In ’t Veld, Sjors G. J. G., Dwarshuis, Govert, van den Broek, Daan, Sol, Nik, Best, Myron G., van Coevorden, Frits, Haas, Rick L., Beijnen, Jos H., van Houdt, Winan J., Würdinger, Tom, Steeghs, Neeltje |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352477/ https://www.ncbi.nlm.nih.gov/pubmed/32471035 http://dx.doi.org/10.3390/cancers12061372 |
Ejemplares similares
-
PropAngio study protocol: a neoadjuvant trial on the efficacy of propranolol monotherapy in cutaneous angiosarcoma—a proof of principle study
por: Heinhuis, Kimberley M, et al.
Publicado: (2020) -
Neoadjuvant Systemic Treatment of Primary Angiosarcoma
por: Heinhuis, Kimberley M., et al.
Publicado: (2020) -
Liquid Biopsies in Sarcoma Clinical Practice: Where Do We Stand?
por: van der Laan, Pia, et al.
Publicado: (2021) -
Blood platelets as an RNA biomarker platform for neuro-oncological diseases
por: Post, Edward, et al.
Publicado: (2022) -
Beta-adrenergic receptor blockade in angiosarcoma: Which beta-blocker to choose?
por: Embaby, Alaa, et al.
Publicado: (2022)